ea0063gp110 | Calcium and Bone 2 | ECE2019
Zavatta Guido
, Vandi Giulia
, Di Dalmazi Guido
, Repaci Andrea
, Ravaioli Matteo
, Cescon Matteo
, Morelli Maria Cristina
, Pagotto Uberto
, Altieri Paola
Introduction: Several risk factors are involved in post-liver transplantation osteoporosis. Immunosuppressive agents, glucocorticoids, decreased renal function associated with secondary hyperparathyroidism and immobilization are the main determinants of fragility fractures in this population. Denosumab is highly effective in increasing bone mineral density (BMD) and preventing fragility fractures. However, the efficacy of denosumab in liver transplantation osteoporosis has nev...